
Quest Diagnostics Incorporated DGX
€ 178.30
0.73%
Quartalsbericht 2026-Q1
hinzugefügt 22.04.2026
Quest Diagnostics Incorporated P/CF 2011-2026 | DGX
P/CF Jährlich Quest Diagnostics Incorporated
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 12.4 | 14.3 | 11 | 9.72 | 7.32 | 7.55 | 17.8 | 14.5 | 15.9 | 16.3 | 17.3 | 16.4 | 18.9 | 9.21 | 12.6 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 18.9 | 7.32 | 13.4 |
P/CF anderer Aktien in der Diagnostik & Forschung
| Name | P/CF | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Enzo Biochem
ENZ
|
-0.00219 | - | -8.98 % | $ 14.8 K | ||
|
Centogene N.V.
CNTG
|
26.1 | - | -6.23 % | $ 30.6 M | ||
|
Heska Corporation
HSKA
|
-38.7 | - | - | $ 1.31 B | ||
|
Celcuity
CELC
|
-35 | $ 95.97 | 3.65 % | $ 4.49 B | ||
|
Akumin
AKU
|
1.15 | - | -17.87 % | $ 25.9 M | ||
|
Co-Diagnostics
CODX
|
-0.201 | $ 4.46 | -0.89 % | $ 5.93 M | ||
|
Fulgent Genetics
FLGT
|
-5.18 | $ 18.75 | 1.32 % | $ 577 M | ||
|
Castle Biosciences
CSTL
|
7.33 | $ 21.44 | 1.68 % | $ 621 M | ||
|
Aspira Women's Health
AWH
|
-0.0975 | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
-0.0826 | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
-0.447 | - | -13.05 % | $ 7.29 M | ||
|
ICON Public Limited Company
ICLR
|
9.76 | $ 153.61 | 1.18 % | $ 12 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
-47.7 | - | - | $ 562 M | ||
|
Guardant Health
GH
|
-72.7 | $ 132.08 | 1.5 % | $ 16.6 B | ||
|
Illumina
ILMN
|
23.4 | $ 165.22 | 3.24 % | $ 25.6 B | ||
|
CareDx, Inc
CDNA
|
23.6 | $ 23.03 | 1.21 % | $ 1.23 B | ||
|
Chembio Diagnostics
CEMI
|
-0.991 | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
-0.541 | - | - | $ 9.42 M | ||
|
Interpace Biosciences
IDXG
|
1.26 | $ 1.74 | 3.57 % | $ 7.7 M | ||
|
HTG Molecular Diagnostics
HTGM
|
-0.162 | - | -20.0 % | $ 1.06 M | ||
|
Global Cord Blood Corporation
CO
|
0.495 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-17.1 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-23.5 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-0.877 | - | 0.12 % | $ 80.1 M | ||
|
NeoGenomics
NEO
|
284 | $ 11.61 | 1.49 % | $ 1.49 B | ||
|
National Research Corporation
NRC
|
11.9 | $ 20.24 | 2.48 % | $ 453 M | ||
|
DermTech
DMTK
|
-0.551 | - | -11.32 % | $ 2.94 M | ||
|
Lantheus Holdings
LNTH
|
13.1 | $ 100.09 | 0.11 % | $ 6.75 B | ||
|
Charles River Laboratories International
CRL
|
10.4 | $ 188.96 | -0.55 % | $ 9.37 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
21.8 | - | - | $ 10.7 B | ||
|
Pacific Biosciences of California
PACB
|
-4.48 | $ 1.41 | 2.55 % | $ 423 M | ||
|
Medpace Holdings
MEDP
|
18.2 | $ 465.31 | -0.32 % | $ 13.4 B | ||
|
Exact Sciences Corporation
EXAS
|
39.7 | - | - | $ 19.8 B | ||
|
Mettler-Toledo International
MTD
|
29.7 | $ 1 159.91 | -0.26 % | $ 23.9 B | ||
|
Myriad Genetics
MYGN
|
227 | $ 4.78 | 5.29 % | $ 443 M | ||
|
Natera
NTRA
|
142 | $ 223.42 | 0.27 % | $ 30.5 B | ||
|
Personalis
PSNL
|
-5.75 | $ 10.11 | 3.64 % | $ 902 M | ||
|
Koninklijke Philips N.V.
PHG
|
26.5 | $ 26.03 | -1.77 % | $ 24.7 B | ||
|
Senseonics Holdings
SENS
|
-5.93 | $ 7.54 | 1.41 % | $ 315 M | ||
|
QIAGEN N.V.
QGEN
|
12.6 | - | - | $ 10.6 B | ||
|
Soleno Therapeutics
SLNO
|
44.5 | - | - | $ 2.69 B | ||
|
Biomerica
BMRA
|
-1.87 | $ 2.03 | -1.02 % | $ 4.66 M | ||
|
Twist Bioscience Corporation
TWST
|
-32.8 | $ 71.38 | 1.88 % | $ 4.27 B | ||
|
Laboratory Corporation of America Holdings
LH
|
14.6 | $ 272.06 | 0.32 % | $ 22.6 B | ||
|
Thermo Fisher Scientific
TMO
|
25.1 | $ 490.53 | -0.77 % | $ 185 B | ||
|
Trinity Biotech plc
TRIB
|
-46.3 | $ 0.67 | 0.87 % | $ 241 M | ||
|
Motus GI Holdings
MOTS
|
-0.0884 | - | -34.28 % | $ 263 K | ||
|
Neogen Corporation
NEOG
|
17.5 | $ 9.35 | 0.65 % | $ 2.03 B | ||
|
Waters Corporation
WAT
|
30.1 | $ 371.06 | -0.02 % | $ 22.1 B |